Discharge Hemoglobin Level and 30-Day Readmission Rates After Coronary Artery Bypass Surgery

Brian C Cho1, Vincent M DeMario1, Michael C Grant1

  • 1From the Department of Anesthesiology/Critical Care Medicine.

Insights

Lower discharge hemoglobin levels after coronary artery bypass grafting (CABG) did not increase 30-day readmission rates. However, severe anemia (hemoglobin <8 g/dL) at discharge may be linked to higher readmission risks.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Anemia Management

Background:

  • Restrictive transfusion strategies are reducing blood use in cardiac surgery.
  • The impact of lower discharge hemoglobin (Hb) levels on readmission rates after coronary artery bypass grafting (CABG) requires further investigation.

Purpose of the Study:

  • To compare 30-day readmission rates in patients undergoing CABG with higher versus lower discharge Hb levels.
  • To evaluate the association between specific anemia severity cohorts and 30-day readmission rates.

Main Methods:

  • Retrospective evaluation of 1552 isolated CABG patients.
  • Comparison of "high" (above mean) and "low" (below mean) discharge Hb cohorts (mean discharge Hb: 9.4 g/dL).
  • Analysis of 4 anemia cohorts (no anemia, mild, moderate, severe) and risk adjustment for multiple factors.

Main Results:

  • No significant difference in 30-day readmission rates between "high" (10.2%) and "low" (12.0%) Hb cohorts (P = .25).
  • Patients with discharge Hb <8 g/dL showed a higher readmission incidence (17.1%) compared to those with Hb ≥8 g/dL (10.6%) (P = .036).
  • Discharge Hb <8 g/dL was a significant predictor of readmission (OR, 1.77; P = .03), with volume overload as the primary readmission cause.

Conclusions:

  • Discharge Hb levels below the institutional mean for CABG patients are not associated with increased 30-day readmission.
  • A potential increased readmission risk is suggested for the small subgroup of patients discharged with Hb <8 g/dL.
  • Further controlled studies are needed to confirm the association between very low discharge Hb and readmission risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
8.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703